Trials / Completed
CompletedNCT01921582
A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder
A Randomized Comparison of Osmotic Release Oral System Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Obese Patients With Binge Eating Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Centre for Addiction and Mental Health · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether methylphenidate is effective in the treatment of binge eating disorder, in a randomized controlled trial extended release methylphenidate versus cognitive behavioral therapy for binge eating disorder in overweight or obese adult females.
Detailed description
Fifty-six adult female outpatients with binge eating disorder will receive 12 weeks of methylphenidate (dosage 18-72 mg) or 12 sessions of manualized cognitive behavioral therapy. Participants will complete interviewer-rated and self-report measures of eating, mood, attention, and personality features before treatment, after 6 weeks of treatment, immediately after treatment is completed, and 3 months after treatment is completed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylphenidate | * Weekly appointments with study psychiatrists for the first four weeks, and then biweekly appointments for the last eight weeks. * Intervention will consist of medication as well as components of "Med-Plus" treatment (e.g., medication management, general support, and compliance enhancement strategies). |
| BEHAVIORAL | Cognitive Behavioral Therapy | Cognitive Behavior Therapy will include three phases: * Phase 1 undertakes to eliminate binge episodes and introduce a 'regular' pattern of eating; * Phase 2 aims to reduce food intake and restructure eating-related cognitions; * Phase 3 focuses upon relapse prevention |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2013-08-13
- Last updated
- 2017-02-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01921582. Inclusion in this directory is not an endorsement.